Stocks
Bristol-Myers (BMY) FCF conversion US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | 5 years average | |||
| FCF conversion, % | 75.7% | 62.2% | 65.3% | 440.1% | 84.3% | 86.4% | |||
| Changes by years, y/y, % | -194pp | -14pp | +3pp | +375pp | -356pp | +146% | |||
Bristol-Myers. FCF conversion, %
Bristol-Myers. FCF conversion, changes, pp
Bristol-Myers (BMY) FCF conversion US GAAP (quarter values) |
||||||||
| FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | FY2026Q2 | LTM ? | |||
| FCF conversion, % | 108.2% | 130.1% | 55.7% | 17.8% | 62.5% | 86.4% | ||
| Changes by years, y/y, % | +61pp | +20pp | -103pp | -20pp | -46pp | |||
| Changes by quarters, q/q, % | +70pp | +22pp | -74pp | -38pp | +45pp | |||
